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ABSTRACT
Human platelets are anucleate cells that lack in deoxyribonucleic acid (DNA), thus hampering genomic 
study on them. However, the presence of their own messenger ribonucleic acid (mRNA) transcript allows 
functional study via the transcriptome approach. Transcriptome not only allows profiling of platelet 
but also aids in studying gene regulation in virus infections and other diseases that have an impact on 
platelets. Some viruses are known to affect the platelet either by causing a reduction or destruction. 
Dengue virus is one of the most postulated virus having such effect and frequently linked to platelet 
reduction. The transcriptome approach has a pivotal role in providing a deeper insight to link certain 
diseases and their effect on platelets. This review critically discusses role of platelet in dengue and other 
viral diseases of public health relevance, with a specific focus on the methods currently used in platelet 
transcriptome profiling. 
Keywords: Anucleate cells, arbovirus, dengue, 
platelet transcriptome profiling, viral diseases
INTRODUCTION
Platelets are a component of blood that 
generally contributes to haemostasis, a 
process to stop bleeding by clumping and 
clotting blood vessel injuries. Platelets are 
anucleate cells derived from megakaryocytes 
in the bone marrow. Once endoplasmatic 
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maturation takes place, megakaryocytes develop pro-platelets, which bud off numerous platelets 
into the bloodstream. This mechanism is accentuated by cytokines such as interleukin 3 (IL-3), 
interleukin 6 (IL-6), granulocyte macrophage colony-stimulating factor (GM-CSF), stromal 
cell-derived factor-1 (SDF-1) and vitally by thrombopoietin (TPO) (Kuter, 2014). Platelet 
is uniquely found in mammals, whereas in other animals such as amphibians and avian, it 
circulates as intact mononuclear cells. The regulation of megakaryocyte and platelet production 
is done by TPO, a hormone produced in the kidneys and liver. In a healthy adult, approximately 
1011 platelets are continuously produced and cleared daily to maintain 150–400 × 109/L of blood 
level (Balduni & Noris, 2014; Grozovsky, Giannini, Falet, & Hoffmeister, 2015).
To examine in depth the function of platelets, researchers have attempted to investigate the 
products of the genome, which are proteins. Proteomics provides details on protein quantity and 
diversity, but on the other hand, it may not depict a cell’s entire story. Moreover, translational 
modification of proteins poses a technical challenge in characterising proteome (Gregorich 
& Ge, 2014). In order to overcome this, measuring the intermediate step between genes and 
proteins, called transcripts of messenger ribonucleic acid (transcriptome), alternatively bridges 
the gap between the genomics and proteomics. 
Transcriptome profiling provides information on up-regulation or down-regulation of 
genes and quantity of gene expression in a cell. This information will be useful to understand 
the mechanism of certain diseases caused by thrombocytopenic condition involving platelets. 
For instance, transcriptional profiling of platelets reveals WD-40 repeat domain 1 (WDR1) 
vanquishes platelet activity and is associated with cardiovascular disease (Montenont et al., 
2016). Other applications of platelet transcriptome profiling include identifying altered platelet 
function due to mutations (Noetzli et al., 2015), monitoring response of anti-platelet therapy in 
hyperthrombic patients (Mao et al., 2014) and potential biomarkers of disease (Best et al., 2015). 
In addition to these applications, platelet transcriptome profiling has the potential to provide 
a breakthrough in viral infections that affect platelets. It is known that thrombocytopenia is 
the hallmark of dengue infection, however only in recent years, researchers have been able to 
prove the replication of dengue virus in platelet (Sutherland et al., 2016; Simon, Sutherland, 
& Pryzdial, 2015). Platelet transcriptome profiling, yet to be used in dengue research could 
be another stepping stone in understanding mechanism of dengue infection, similarly in other 
viral infections too. 
HUMAN PLATELET TRANSCRIPTOME
Human platelets are known to be anucleate, lacking in DNA and produced as cytoplasmic 
buds from megakaryocytes, they retain megakaryocyte-derived messenger ribonucleic acid 
(mRNA) (Bahou & Gnatenko, 2004). There is a paucity of studies on platelet transcriptome; 
however, steady observations support the fact that platelet mRNA is biologically and patho-
physiologically significant. Earlier studies show platelet transcriptome directly correlates with 
proteomic data indicating that transcriptional analysis can provide insight on platelet function 
and disorders. Adversely, one study reports a weak association of proteome data with human 
platelet transcriptome obtained from the healthy male individual (Londin et al., 2014). Having 
Platelet Transcriptome to Fight Diseases
935Pertanika J. Sci. & Technol. 26 (3): 933 - 946 (2018)
said that, to date, it has been revealed that approximately 69% of secreted platelet-associated 
proteins are detectable at the mRNA level (McRedmond et al., 2004). 
Additionally, 2000 mRNA transcripts are found to be present in unstimulated platelets, thus 
providing a better chance for evaluation of the transcriptome (Gnatenko et al., 2003). It is also 
believed that platelet transcriptome is fixed, with minimal changes indicating that significant 
changes in transcripts may need days compared to hours for nucleated cells. An interesting 
data to note, 58% of the mRNAs expressed by human platelets are found in mouse platelets 
while 83% vice versa (Rowley et al., 2011). In addition, transcriptome profiling reveal platelet 
has 50%-90% less ribosomal RNA, high levels mRNA and small RNAs and contains various 
isoforms of mRNA (Bray et al., 2010).
Prior investigation on platelet mRNA show integrins and glycoproteins are significantly 
higher compared with other components (Bugert & Kluter, 2006). The over-presentation 
of integrins may reflect their utmost importance in biological functions of the platelet. 
Transcriptome data have allowed novel discovery of transporters for gamma-aminobutyric acid 
(GABA), glutamate and dopamine molecules in platelets (Frankhauser et al., 2006; Rainesalo, 
Keranen, Saransaari, & Honkaniemi, 2005).
It is useful to characterise platelet transcriptome to identify the genetic aspect of disease 
and disease traits. Capturing primary megakaryocytes mRNA profile is not feasible when it 
involves many subjects. Thus, profiling platelet RNA is an alternative as it is easy to be procured 
compared with to megakaryocytes. There are several methods to study the platelet transcriptome 
of which some may become obsolete due to advancement in molecular methods (Figure 1).
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Platelet profiling can be performed via the transcriptomic and proteomic approaches. On the 
other hand, genomic approach is not possible as the platelets do not have nuclear DNA. 
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transcription, a step ahead of protein translation (proteomic approach). Three identified 
methods of platelet transcriptome profiling are serial analysis of gene expression (SAGE), 
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Platelet profiling can be performed via the transcriptomic and proteomic approaches. On 
the other hand, genomic approach is not possible as the platelets do not have nuclear DNA. 
Transcriptomic profiling enables characterisation of platelet at the stage of mRNA transcription, 
a step ahead of protein translation (proteomic approach). Three identified methods of platelet 
transcriptome profiling are serial analysis of gene expression (SAGE), microarray analysis 
and next generation sequencing (NGS). Microarray analysis and NGS are advanced methods 
which are currently preferred by researchers as tools for platelet profiling.
THE LINK BETWEEN PLATELET AND DENGUE INFECTION
Dengue is a mosquito-borne viral disease of public health importance (Benelli & Mehlhorn, 
2016). Platelet reduction, also known as thrombocytopenia is a hallmark of dengue virus 
infection. However, the actual mechanism on how dengue virus affects platelet during infection 
is not well understood. Besides, there are variations in research findings that make it difficult 
to come to a consensus conclusion on the link between platelet and dengue virus. 
Recent studies demonstrated that dengue virus binds to lectin receptor and triggers platelet 
activation and apoptosis, which generates inflammatory responses in target monocytes (Hottz 
et al., 2014; Sun et al., 2007). Contradictory to this, a study observed the presence of dengue 
RNA in a highly augmented CD61 (+) cell population from infected rhesus monkey during the 
acute phase (Noisakran et al., 2012). This result may suggest that dengue virus utilises CD61 
receptor for binding to the platelet. Another research reported the detection of dengue virus in 
platelets isolated from dengue patients (Noisakran et al., 2009). This raised the possibility of 
dengue virus replicating in platelet cells. In a most recent study in 2015, researchers provide 
the first evidence that dengue virus attacks platelets and utilise their translational machinery 
to replicate and produce infectious virus (Simon, Sutherland, & Pryzdial, 2015). 
A prospective observational study in India found significant correlation between platelet and 
duration of hospitalisation of dengue patients. A decline in platelet level increases complication 
rate and prolonged hospitalisation, thus platelet count can be utilised as a predictive parameter 
(Jayanthi & Thulasi, 2016). In another study, correlation of bleeding manifestation and platelet 
count is assessed in patients with severe dengue. The study, however, finds poor correlation 
between thrombocytopenia and bleeding manifestations (Sreenivasa, Manjunatha, & Nivil, 
2016). This perhaps indicates that abnormal platelet aggregation or disseminated intravascular 
coagulation may contribute to bleeding in severe dengue cases rather than number of platelets.
New evidence on correlation between activation and depletion of platelets in dengue 
patients with thrombocytopenia has surfaced. The findings a study show a substantial decrease 
in platelet count occur on day four of fever in dengue patients. Furthermore, high copy numbers 
of dengue virus genome in platelet pellet directly correlated with the platelet activation markers 
during day four, six and eight of fever are observed. Based on the observation that platelet 
activation is an important determinant of thrombocytopenia in dengue infections, the study 
suggests a controlled strategy of platelet inactivation may save them from rapid decline during 
dengue infections (Ojha et al., 2017).
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PLATELETS AND OTHER VIRAL INFECTIONS
Platelet activation is not only limited to responding to injury but also indicates host response and 
virus survival. Thrombocytopenia, a condition due to either decreased in platelet synthesis or 
increased in platelet destruction, is common following certain viral infections (Table 1). Viruses’ 
ability to diminish the levels of circulating platelets is a multifactorial event and differs based 
on the mechanism. For instance, simian immunodeficiency virus (SIV) alters TPO production 
in the liver by up-regulating tumour growth factor beta (TGF β) (Pate et al., 2014) whereas 
hepatitis C virus (HCV) induces bone marrow suppression and hypersplenism (Fouad, 2013). 
The spleen size is inversely correlated to platelet count in patients with chronic HCV infection 
(Medeiros, Domingues, Luna, & Lopes, 2014; van der Meer et al., 2016). 
Platelet destruction, on the other hand, occurs via direct interaction of platelets and virus. 
Some viruses have the tendency to bind to platelet by utilising receptors, which enhance the 
interaction of platelets and neutrophils. Subsequently, platelets are phagocytised, thus, reducing 
the number of circulating platelets. Besides that, a reduction in platelet count sometimes is 
caused by self-destruction due to the presence of anti-platelet autoantibody. This leads to 
a condition called idiopathic thrombocytopenic purpura (ITP) that is commonly caused in 
HCV, cytomegalovirus (CMV), Human Immunodeficiency virus (HIV), Epstein Barr virus 
(EBV), Varicella Zoster virus (VZ) and herpes viruses (Assinger, 2014; Assinger et al., 2014; 
Goeijenbier et al., 2012). Studies have shown antibodies produced by B-lymphocytes against 
these viruses interrupt the surface integrins on the platelet such as the GPIIb/IIIa or GPIb-IX-V 
and diminish survival of platelets (Hamidpour, Behrendt, Griffiths, Partridge, & Lindsey, 2006; 
Najaoui et al., 2012).
HOW PLATELET TRANSCRIPTOME CAN BE USED TO STUDY 
MECHANISMS OF DENGUE INFECTION IN PLATELET
To establish an infection, almost all viruses exhibit the same modus operandi, which includes 
entry to the host’s cells, replication via hosts’ internal machinery and release of new virions (Li 
& Nagy, 2011). However, some viral replication mechanisms are less understood due to lack 
of laboratory evidences. For instance, replication of dengue virus in platelets remains unclear 
until recent study shows that dengue virus uses platelets to replicate (Simon, Sutherland, & 
Pryzdial, 2015). Thus, the key to unveiling further about dengue replication lies within the 
platelet, and platelet transcriptome can be utilised to study the mechanism of infection by 
dengue virus. To date, platelet transcriptome profiling has yet to be used as a tool to study the 
mechanism of dengue infection. One proposed method for future research includes in vitro 
study comparing the platelet transcriptome before and after dengue virus infection to identify 
genes, which are involved in virus transcription. Apart from that, it would be interesting to 
analyse platelet transcriptome profile at different phases of dengue infection or based on the 
severity of the disease.
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METHODS OF PLATELET TRANSCRIPTOME PROFILING
Platelet Transcriptome Profiling Approach by SAGE
The serial analysis of gene expression (SAGE) is a quantitative method for measuring gene 
expression; it was first, developed and published in 1995 (Velculescu, Zhang, Vogelstein, & 
Kinzler, 1995). Though lower in throughput than microarray analysis, SAGE provides a more 
detailed transcriptome profiling due to its quantitative property while microarray has been 
just a qualitative method. The difference between SAGE and microarray has been widely 
Table 1 
Mechanisms of action of selected viral infections on platelet 
Virus Mechanism of action on platelet Study
Simian 
Immunodeficiency 
Virus (SIV)
SIV alters Hepatic thrombopoietin (TPO) 
production by up-regulating tumour growth 
factor.
Pate et al., 2014
Hepatitis C virus 
(HCV)
HCV interacts with platelets through collagen 
receptor GPVI. It stimulates bone marrow 
suppression and hypersplenism. The size of the 
spleen is inversely related to platelet count.
van der Meer et al., 2016
Cytomegalovirus 
(CMV)
CMV is known to replicate in megakaryocyte. 
CMV binds to platelet via the TLR2 receptor, 
initiating platelet activation and degranulation. 
This results in enhanced platelet interaction with 
neutrophils, phagocytosis, and drop in platelet 
count.
Assinger et al., 2014 
Human 
immunodeficiency 
virus (HIV)
Multiple mechanisms: (1) Reduce survival of 
megakaryocytes and precursors; (2) HIV surface 
glycoprotein gp120 binds to lection receptor and 
leads to increased megakaryocyte apoptosis; (3) 
reduce TPO receptor (c-Mpl) expression.
Assinger, 2014
Hantavirus Binds to αvβ3 or αIIbβ3 integrins expressed 
on platelets and endothelial cells, contributing 
to viral dissemination, platelet activation, and 
induction of endothelial cell functions.
Zapata, Cox, & Salvato, 2014
Epstein Barr Virus 
(EBV) Dengue virus
Interact with platelets by complementing receptor 
2 (CR2) and induces platelet activation.
Ahmad & Menezes, 1997 
Hottz et al., 2014 
Sun et al., 2007
Noisakran et al., 2009
Bind to lectin receptor and enhance platelet 
activation and apoptosis, which generates 
inflammatory responses in target monocytes. 
Anti-non-structural protein-1 (NS-1) triggers 
complement-mediated lysis of platelets which 
further accelerates thrombocytopenia. Dengue 
virus has been detected inside the platelet, raising 
the possibility of direct replication in platelet.
Rotavirus Rotavirus binds to platelet using collagen receptor 
GPIa/IIa thus triggering platelet activation and 
destruction.
Assinger, 2014
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studied (Gnatenko et al., 2003). The study identified 89% of platelet mRNA transcripts are of 
mitochondrial origin, while 11% corresponds to unique genes which are not even detected by 
microarray. Therefore, SAGE is a good technique that may permit full characterisation of the 
mRNA transcripts including non-mitochondrial origin. Nevertheless, with the development of 
high-throughput sequencing technologies and more advanced microarray techniques, it appears 
possible that SAGE may be surpassed in future studies as detailed in Table 2.
Platelet Transcriptome Profiling by NGS
Next-generation sequencing (NGS) of platelets has enabled exceptional quantification and 
profiling of platelet transcriptome and discovered the diversity of mRNAs. The NGS has 
wide applications in this aspect, such as comparing platelet transcriptome between virus-
infected and non-infected cells. One study uses NGS approach to evaluate various pathogen 
reduction systems (PR) for platelet storage (Osman, Hitzler, Ameur, & Provost, 2015). PR 
systems function to extend the shelf life of stored blood components, such as platelets and 
inhibit infections transmitted via transfusion. It is found that use of certain PR systems greatly 
reduces mRNA level in PR-treated platelet concentrates compared with non-treated platelet. 
This finding will be useful in alerting the blood bank authorities in implementing appropriate 
PR system for blood component storage (Osman, Hitzler, & Provost, 2016).
The NGS is also used to compare platelet transcriptome between mice and human (Rowley 
et al., 2011). Mouse platelets are commonly used as surrogates to study in vivo human platelet 
function. Still, uncertainty often arises regarding the functional differences and similarities 
between mouse and human platelets. This is the first study that utilises NGS to analyse human 
and mice platelet. The study discovered 95% conserved platelet transcriptome between human 
and mice. Conservation of platelet mRNA between two species enables mice model to be used 
to study haemostasis.
Though next-generation sequencing enables large scale platelet transcriptome profiling, 
its application for clinical studies is confined. NGS is foreseen to replace some of the old 
techniques used in the clinical setting. For instance, it may be used in assessing aspirin resistance 
in heart disease patients. To date, the influence of aspirin is commonly evaluated using light 
transmission aggregometry (LTA) and thrombelastography platelet mapping assay (TEG) (Liu 
et al., 2013). NGS approach to determine the platelet mRNA profile in association with aspirin 
resistance will provide more data in predicting genetic markers of aspirin responsiveness. The 
NGS generates a large transcript data per sample, and therefore, it is challenging to perform 
analysis with such data. The RNA sequencing in a much larger population will need to be 
performed so that a normal platelet transcript can be established (Freedman, 2011).
Microarray Analysis in Characterisation of Platelet Transcriptome
Apart from NGS, microarray analysis is another method commonly used for platelet 
transcriptome profiling. This method is beneficial in observing up-regulation and down-
regulation of genes without the need for quantification as applied by NGS. One study had 
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attempted to compare platelet transcriptome from three unrelated donors by using leukocyte 
depleted platelet subjected to hybridisation to the Affymetrix HG-U95Av2 GeneChip, consisting 
of 12,600 probe sets. It found exceptional concordance, reproducibility and discrete profiles of 
human platelets among the three donors (Bahou & Gnatenko, 2004). In a most recent study, 
microarray analysis is performed to compare neonate and adult human platelet transcriptomes 
using pure platelet RNA obtained from adult and cord blood. Interestingly, 201 genes are found 
to be differentially expressed between these two groups of which neonatal platelets had higher 
amounts of mRNA that are associated with protein synthesis and lower levels of genes involved 
in calcium metabolism and cell signalling (Caparrós-Pérez et al., 2017).
Microarray approach seems to be more feasible for clinical application. Coronary heart 
disease is a condition in which platelet aggregation occurs and genetically modulated (Floyd, 
Ellis, & Ferro, 2014). Hereditary platelet glycoprotein polymorphisms are a known risk 
factor for coronary heart disease. The gene encoding glycoprotein GPIIIa has displayed a 
polymorphism (PlA2 allele) that is linked to vascular disease. Several case report studies 
identified the presence of this polymorphism in patients who died of myocardial infarction, 
stroke and related heart diseases (O’Donnell et al., 2001). It would be interesting to utilise 
microarray for comparison profiling of this platelet-related gene in patients who possess 
heterozygous or homozygous condition of the allele. In addition, platelet transcriptome analysis 
by microarray is useful in chronic kidney disease patients (CKD). An alteration in the uremic 
platelet mRNA is observed in CKD patients (Ple et al., 2012). However, dialysis appeared to 
have corrected this defect, which is consistent with the favourable effect of dialysis.
The microarray platelet profile is also helpful in providing insight into transcriptional 
signaling pathways in platelets in sickle cell anaemia disease. A study utilising microarray 
identified the absence of expression of CD45 and CD5 in sickle cell anaemic patients. These 
are lymphocytes and T cells markers. On the other hand, significant up-regulation of mRNAs 
encoding arginase II and ornithine decarboxylase antizyme in patients with sickle cell disease 
is observed in comparison with control subjects. It is known that arginine metabolic enzymes 
are involved in homeostasis (Raghavachari et al., 2007).
Microarray approach may have its limitations. There is no standardised method for 
microarray data analysis that, can contribute to inter-laboratory variations. Microarray assays 
also require a minimum of 5 mg of total cellular RNA as starting material, thus to prepare 
pure leukocyte depleted platelet RNA, a large volume of blood may be needed (Gnatenko 
et al., 2003). In addition, the microarray is no doubt a very costly method, which may be a 
prohibitive factor in a large-scale study of platelet transcriptome. This factor should be taken 
into stringent consideration when customising the microarray probe chips in regard to which 
gene should be spotted (Eicher et al., 2016). Prioritising the importance of genes to be spotted 
and prior knowledge is required to prevent wastage of data and prohibitive cost. 
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CONCLUSION
In sum, the study has highlighted that platelets are well suited for transcriptomic studies, as they 
lack nuclear DNA and their genome consists of megakaryocytes derived mRNA transcripts. 
There are many available transcriptomic approaches and analysis methods. While microarray 
is one of the widely-employed methods, next-generation sequencing is gradually becoming 
a favoured tool for transcriptome analysis. However, the limitations of modern transcript 
profiling include lack of reproducibility, difficulty in data processing and complexity of data 
Table 2 
Current knowledge on platelet profiling 
Method Key findings Up-regulated/down-regulated Reference
SAGE Detected 89% mitochondrial transcripts 
and  11% of  non-mi tochondr ia l 
transcripts.
- Gnatenko et 
al., 2003 
Microarray Detected mainly unknown function 
genes, genes involve in metabolism 
and receptors.
Majority of the up-regulated 
genes are unknown functional 
genes.
Gnatenko et 
al., 2003
Microarray Detected abundant glycoproteins and 
integrins
Glycoprotein/integrins and 
receptors are majorly up-
regulated.
Bugert & 
Kluter, 2006 
Microarray Human platelet transcriptome correlated 
well with proteome profile.
- McRedmond 
et al., 2004
Microarray Evaluation of platelet profile from 3 
healthy donors revealed concordance, 
reproducibility and distinct profiles of 
human platelets.
- Bahou & 
Gnatenko, 
2004 
Microarray An alteration of the uremic platelet 
mRNA is observed in CKD patients. 
Dialysis appeared to have corrected 
this defect, which is consistent with the 
favourable effect of dialysis.
2 3  a n d  1 7  m R N A s  a r e 
differentially expressed in 
platelets from dialysis and 
uremic patients respectively 
Defective genes such as PCTP, 
RAB1A, ZFAND5, and USP15 
are corrected by dialysis.
Ple et al., 
2012 
Microarray Demonstrated down-regulation of 
transcriptional signaling pathways in 
platelets in sickle cell anaemia patients.
CD45 and CD5 are down-
regulated; arginase II and 
o r n i t h i n e  d e c a r b o x y l a s e 
antizyme ae up-regulated.
Raghavachari 
et al., 2007
NGS Abnormal transcript reads detected 
from an individual with autosomal 
recessive gray platelet syndrome.
Mutation in NBEAL2 gene 
responsible for causing gray 
platelet syndrome.
Kahr et al., 
2011 
NGS Evaluated various pathogen reduction 
systems (PR) for platelet storage and 
finds that Intercept system alters platelet 
quality.
- Osman et al., 
2015
NGS 95% conserved platelet transcriptome 
between human and mice enables mice 
model to be used to study haemostasis.
- Rowley et al., 
2011
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produced. Despite that, these methods are still reliable in clinical applications. In future, platelet 
transcriptome studies investigating a more diverse set of healthy and diseased samples will 
add value to the existing knowledge on platelet thrombotic and non-thrombotic functions.
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